• Room 02.005 - CCRCB Block 5 MBC Site

    United Kingdom

Accepting PhD Students

20002019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Paul Mullan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 64 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
asparaginylendopeptidase Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2018

Research Output 2000 2019

Defining the molecular evolution of extrauterine high grade serous carcinoma

Beirne, J. P., McArt, D. G., Roddy, A., McDermott, C., Ferris, J., Buckley, N. E., Coulter, P., McCabe, N., Eddie, S. L., Dunne, P. D., O'Reilly, P., Gilmore, A., Feeney, L., Ewing, D. L., Drapkin, R. I., Salto-Tellez, M., Kennedy, R. D., Harley, I. J. G., McCluggage, W. G. & Mullan, P. B., 04 Sep 2019, In : Gynecologic Oncology. 155, 2, p. 305-317 13 p.

Research output: Contribution to journalArticle

Molecular Evolution
Carcinoma
Fallopian Tubes
Carcinoma in Situ
Epithelium
1 Citation (Scopus)
Open Access
File
Tumor Microenvironment
Colorectal Neoplasms
Fibroblasts
Epithelial Cells
Bone Morphogenetic Proteins

Identification and SAR exploration of a novel series of Legumain inhibitors

Eddie, S. L., Gregson, A., Graham, E., Burton, S., Harrison, T., Burden, R., Scott, C. J., Mullan, P. B. & Williams, R., 15 Jun 2019, In : Bioorganic & Medicinal Chemistry Letters. 29, 12, p. 1546-1548 3 p.

Research output: Contribution to journalArticle

asparaginylendopeptidase
Dipeptides
Molecules
Research
Experiments
1 Citation (Scopus)

NUP98 – a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

Mullan, P. B., Bingham, V., Haddock, P., Irwin, G. W., Kay, E., McQuaid, S. & Buckley, N. E., 02 Apr 2019, In : BMC Cancer. 19, 13 p., 236.

Research output: Contribution to journalArticle

Open Access
File
Triple Negative Breast Neoplasms
Anthracyclines
Drug Therapy
Standard of Care
Biomarkers
Breast Neoplasms
Growth
Protein Binding
Cell Proliferation
Co-Repressor Proteins

Impact

Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)

Impact: Health Impact, Quality of Life Impact